Back

Preliminary results of the France LEADLESS study. A safety and effectiveness monitoring of a new ventricular leadless pacemaker.

31 March 2025 (14:30 - 15:15)
Organised by: Logo
Congress Presentation Part of: Pacing therapy Antibradycardia Pacing EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Pascal Defaye

CHU Grenoble, Grenoble (France)

6 More presentations in this session

Presentation thumbnail
First european experience with a leadless atrial pacemaker
Mr E. von Felten (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
A higher pacing rate more effectively reduces central blood pressure in patients with sick sinus syndrome and hypertension
Doctor S. Heinsar (Tallinn, EE)
Abstract Slides Video
Presentation thumbnail
Predictive factors of high burden of ventricular pacing in patients undergoing permanent pacemaker implantation after transcatheter aortic valve implantation
Doctor C. Chaumont (Rouen, FR)
Abstract Slides Video
Presentation thumbnail
Correlation between manual and automatic measurements of the atrial signal in VDD leadless pacemakers (Micra AV)
Doctor T. Van Weyenbergh (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
one-year outcomes of the first 1000 patients implanted with th micra AV leadless pacing system in france: the AV-CESAR cohort study
Doctor F. kerkouri (Brest, FR)
Abstract Slides

Access the full session

Session thumbnail
Pacing therapy

The Event

Event poster

EHRA 2025

31 March 2025 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Safety profile of a ventricular leadless pacemaker. Data from 1265 patients in the France LEADLESS study.
thumbnail
Congress Session
Leadless pacemaker
thumbnail
Congress Presentation
12 years of leadless pacing: what did we learn?

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources